Telehealth has become a major source of healthcare during the Covid-19 pandemic, accounting for around 5 percent of all health insurance claims, primarily for behavioral health. However, geographical distance between patient, provider and pharmacist continues to create obstacles, especially with regard to prescriptions for controlled substances. The upcoming rules from the U.S. Drug Enforcement Administration (DEA) could potentially heighten these barriers. The ATA suggests creating a Special Registration process for remote prescribing of controlled substances to ensure prescriptions are legitimate, and a safe harbor for pharmacists dispensing remote prescriptions.
Microsoft Legal Action Disrupts RedVDS Cybercrime Infrastructure Used for Online Fraud
Microsoft on Wednesday announced that it has taken a “coordinated legal action” in the U.S. and the U.K. to disrupt a cybercrime subscription service called
